0.344
price down icon5.74%   -0.0209
after-market 시간 외 거래: .35 0.006 +1.74%
loading
전일 마감가:
$0.3649
열려 있는:
$0.385
하루 거래량:
434.57K
Relative Volume:
0.90
시가총액:
$7.38M
수익:
-
순이익/손실:
$-51.21M
주가수익비율:
-0.044
EPS:
-7.82
순현금흐름:
$-44.62M
1주 성능:
-9.59%
1개월 성능:
-5.57%
6개월 성능:
-70.85%
1년 성능:
-87.97%
1일 변동 폭
Value
$0.34
$0.386
1주일 범위
Value
$0.34
$0.412
52주 변동 폭
Value
$0.33
$2.9077

Aptose Biosciences Inc Stock (APTO) Company Profile

Name
명칭
Aptose Biosciences Inc
Name
전화
310-849-8060
Name
주소
66 WELLINGTON STREET WEST, SUITE 5300, TORONTO, ON
Name
직원
36
Name
트위터
Name
다음 수익 날짜
2024-11-07
Name
최신 SEC 제출 서류
Name
APTO's Discussions on Twitter

APTO을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
APTO 0.344 7.38M 0 -51.21M -44.62M -7.82
VRTX 467.01 119.87B 10.63B -479.80M -1.35B 13.33
REGN 762.00 83.27B 13.85B 4.65B 3.32B 35.06
ARGX 567.90 33.96B 1.86B -40.29M -1.28B -4.16
ALNY 232.27 30.18B 2.09B -332.26M 16.06M -4.14
BNTX 101.87 24.42B 3.30B -501.07M 1.03B 11.54

Aptose Biosciences Inc Stock (APTO) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2020-10-19 개시 Cantor Fitzgerald Overweight
2020-09-22 개시 Alliance Global Partners Buy
2020-02-20 개시 Maxim Group Buy
2020-02-06 재확인 H.C. Wainwright Buy
2020-01-09 개시 Piper Sandler Overweight
2019-03-01 개시 RBC Capital Mkts Outperform
2018-11-16 개시 B. Riley FBR Buy
2017-12-13 재확인 H.C. Wainwright Buy
2017-10-23 재개 ROTH Capital Buy
2017-09-07 업그레이드 H.C. Wainwright Neutral → Buy
2017-06-08 개시 Rodman & Renshaw Neutral
모두보기

Aptose Biosciences Inc 주식(APTO)의 최신 뉴스

pulisher
Nov 14, 2024

ARMISTICE CAPITAL, LLC Increases Stake in Aptose Biosciences Inc - GuruFocus.com

Nov 14, 2024
pulisher
Nov 12, 2024

Aptose Biosciences Inc. (APTO) Quarterly 10-Q Report - Quartzy

Nov 12, 2024
pulisher
Nov 08, 2024

Aptose Biosciences Reports Q3 2024 Financial Highlights - TipRanks

Nov 08, 2024
pulisher
Nov 08, 2024

Aptose Reports Results for the Third Quarter 2024 - GlobeNewswire

Nov 08, 2024
pulisher
Nov 08, 2024

Aptose Biosciences Cuts Q3 Losses, Secures $10M Loan Amid Nasdaq Challenges | APTO Stock News - StockTitan

Nov 08, 2024
pulisher
Oct 05, 2024

Aptose Biosciences faces delisting from NASDAQ - Investing.com India

Oct 05, 2024
pulisher
Oct 04, 2024

Aptose Biosciences faces delisting from NASDAQ By Investing.com - Investing.com South Africa

Oct 04, 2024
pulisher
Sep 18, 2024

Analysts’ New Coverage for September 18th (AINC, AIRI, APTO, ARM, AVGO, BGNE, CAN, CARA, CHH, CLLS) - Defense World

Sep 18, 2024
pulisher
Sep 09, 2024

Aptose Biosciences secures shareholder nod for warrant issuance - Investing.com

Sep 09, 2024
pulisher
Sep 09, 2024

Aptose Biosciences stock hits 52-week low at $0.34 - Investing.com

Sep 09, 2024
pulisher
Sep 05, 2024

Aptose Biosciences Shareholders Endorse Key Resolutions - TipRanks

Sep 05, 2024
pulisher
Sep 05, 2024

Aptose Announces Results from Special Meeting of Shareholders - GlobeNewswire

Sep 05, 2024
pulisher
Sep 04, 2024

A significant driver of top-line growth: Aptose Biosciences Inc (APTO) - SETE News

Sep 04, 2024
pulisher
Sep 03, 2024

Aptose Biosciences Inc Inc. (APTO) Price Performance: A Technical Analysis Perspective - The InvestChronicle

Sep 03, 2024
pulisher
Sep 03, 2024

APTO’s earnings forecast for the current quarter - US Post News

Sep 03, 2024
pulisher
Sep 03, 2024

Daily Market Movement: Aptose Biosciences Inc (APTO) Sees a 2.19 Increase, Closing at 0.41 - The Dwinnex

Sep 03, 2024
pulisher
Sep 03, 2024

Hello Group, Zscaler And 3 Stocks To Watch Heading Into Tuesday - Benzinga

Sep 03, 2024
pulisher
Sep 02, 2024

Aptose Biosciences secures funds for AML treatment development - Pharmaceutical Technology

Sep 02, 2024
pulisher
Sep 02, 2024

Aptose Biosciences (NASDAQ:APTO) Receives New Coverage from Analysts at StockNews.com - Defense World

Sep 02, 2024
pulisher
Aug 31, 2024

Aptose secures $10 million loan for leukemia drug development - Investing.com India

Aug 31, 2024
pulisher
Aug 30, 2024

APTOAptose Biosciences, Inc. Latest Stock News & Market Updates - StockTitan

Aug 30, 2024
pulisher
Aug 30, 2024

Aptose Biosciences Secures Convertible $10M Loan from Hanmi - TipRanks

Aug 30, 2024
pulisher
Aug 30, 2024

Aptose Receives $10 Million Through a Facility Agreement with Hanmi; Negotiating Future Collaboration Agreement with Hanmi to Jointly Develop Tuspetinib - Yahoo Finance

Aug 30, 2024
pulisher
Aug 30, 2024

Aptose Receives $10 Million Through a Facility Agreement - GlobeNewswire

Aug 30, 2024
pulisher
Aug 25, 2024

StockNews.com Begins Coverage on Aptose Biosciences (NASDAQ:APTO) - Defense World

Aug 25, 2024
pulisher
Aug 22, 2024

Aptose Biosciences stock hits 52-week low at $0.4 amid downturn - Investing.com

Aug 22, 2024
pulisher
Aug 22, 2024

APTO’s Market Whiplash: -81.82% YTD Decline, -24.89% Plunge in 30 Days - The InvestChronicle

Aug 22, 2024
pulisher
Aug 22, 2024

Market Resilience: Aptose Biosciences Inc (APTO) Finishes Weak at 0.46, Down -4.82 - The Dwinnex

Aug 22, 2024
pulisher
Aug 17, 2024

Aptose Biosciences (NASDAQ:APTO) vs. ImmunityBio (NASDAQ:IBRX) Critical Review - Defense World

Aug 17, 2024
pulisher
Aug 15, 2024

Aptose Biosciences: Bottom 25 Performing Stocks Year-To-Date On TSX (APS) - Barchart

Aug 15, 2024
pulisher
Aug 15, 2024

Aptose Announces Adjournment of its Special Meeting of Shareholders - GlobeNewswire

Aug 15, 2024
pulisher
Aug 10, 2024

Aptose Biosciences (NASDAQ:APTO) Releases Quarterly Earnings Results, Beats Expectations By $0.15 EPS - Defense World

Aug 10, 2024
pulisher
Aug 09, 2024

APTO Stock Earnings: Aptose Biosciences Beats EPS for Q2 2024 - MSN

Aug 09, 2024
pulisher
Aug 09, 2024

Aptose Biosciences: Q2 Earnings Snapshot - Houston Chronicle

Aug 09, 2024
pulisher
Aug 09, 2024

Aptose Biosciences (NASDAQ:APTO) Now Covered by StockNews.com - Defense World

Aug 09, 2024
pulisher
Aug 08, 2024

Aptose Reports Results for the Second Quarter 2024 - GlobeNewswire

Aug 08, 2024
pulisher
Aug 02, 2024

Aptose Biosciences Inc (APS-T) QuotePress Release - The Globe and Mail

Aug 02, 2024
pulisher
Aug 02, 2024

Aptose Biosciences stock hits 52-week low at $0.55 amid downturn - Investing.com Australia

Aug 02, 2024
pulisher
Aug 01, 2024

Aptose Biosciences (NASDAQ:APTO) Coverage Initiated by Analysts at StockNews.com - Defense World

Aug 01, 2024
pulisher
Jul 30, 2024

Caspase 3 Market – 37% of Growth to Originate from APAC -Aptose Biosciences Inc, BeyondSpring Pharmaceuticals Inc, Conat – Moose Gazette - Moose Gazette

Jul 30, 2024
pulisher
Jul 26, 2024

Aptose Biosciences Inc. (NASDAQ:APTO) Receives Average Recommendation of “Buy” from Brokerages - Defense World

Jul 26, 2024

Aptose Biosciences Inc (APTO) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$18.98
price up icon 3.66%
$76.97
price up icon 1.45%
$39.51
price up icon 7.22%
$359.21
price down icon 1.11%
$187.69
price down icon 0.81%
$101.87
price up icon 2.16%
자본화:     |  볼륨(24시간):